Related Experiment Videos
Assessment of executive function in clinical trials
Raija Ylikoski1, Tuomo Hänninen
1Helsinki University Central Hospital, Department of Neurology, HUS, Finland.
International Psychogeriatrics
|September 30, 2005
Summary
Vascular cognitive impairment, often following stroke, frequently involves executive dysfunction. This review covers key neuropsychological tests and methodological considerations for clinical trials investigating cognitive function in cerebrovascular disease.
Area of Science:
- Neurology
- Neuropsychology
- Cognitive Science
Background:
- Cerebrovascular disease and stroke significantly increase the risk of cognitive impairment.
- Executive dysfunction is a primary neuropsychological deficit observed in vascular cognitive impairment and vascular dementia.
Purpose of the Study:
- To define essential subcomponents and concepts of executive function relevant to clinical trials.
- To review commonly used neuropsychological tests for assessing executive function.
- To discuss methodological aspects of clinical trials in this rapidly evolving field.
Main Methods:
- Literature review of scientific research and new methodologies.
- Analysis of commonly employed neuropsychological tests.
- Discussion of methodological considerations for clinical trial design.
Main Results:
- Identification of key executive function subcomponents.
- Overview of validated neuropsychological assessment tools.
- Highlighting critical methodological aspects for research.
Conclusions:
- Accurate assessment of executive function is crucial for understanding cognitive impairment in cerebrovascular disease.
- Standardized methodologies and appropriate tests are essential for reliable clinical trial outcomes.
- Continued research is vital to advance the diagnosis and treatment of vascular cognitive impairment.